Crossmark

Metabolic dysfunction–associated steatotic liver disease (MASLD): a new disease category within the steatotic liver disease (SLD) framework

Published Online: 2025-12-24

Published Print: 2026-03

Authors

Nishie, Akihiro

Aoki, Takatoshi

Yoshiura, Takashi
License Information

Text and Data Mining valid from 2025-12-24

Version of Record valid from 2025-12-24
More Information

Article History

First Online: 24 December 2025

Declarations

:

: AN received a research grant from Canon Medical Systems. TY received a research grant from Shin Nippon Biomedical Laboratories, Ltd.

Free to read: This content has been made available to all.

Document is current